NCT00985959 2013-12-02A Study of JNJ-26866138 (Bortezomib) in Untreated Multiple Myeloma Patients Who Are Not Candidates for Hematopoietic Stem Cell Transplant (HSCT)Janssen Pharmaceutical K.K.Phase 1 Completed101 enrolled 15 charts